14 April 2009
Fort Dodge Provides Bluetongue 1 Vaccine to Farmers in Jersey
Amsterdam, 14 April 2009 – Fort Dodge Animal Health, a division of Wyeth (NYSE: WYE), has provided its Zulvac® 1 vaccine against Serotype 1 Bluetongue (BTV-1) in cattle and sheep to veterinary surgeons in Jersey under the terms of a Special Export Licence from the French Government.
Fort Dodge was the first company to be appointed by the French authorities to supply a Serotype 1 vaccine and it has been used extensively to combat the major problem posed by this variant of Bluetongue in France. As no company has yet been licensed to provide a Serotype 1 vaccine in the UK, Fort Dodge has stepped in to support farmers in Jersey who face a serious threat from Bluetongue Serotype 1 because of their proximity to France. Zulvac® 1 is currently awaiting its UK licence.
Commenting on this announcement, Linda Lowseck, States Veterinary Officer at the Planning and Environment Department in Jersey, said: "I'm pleased to have worked with Fort Dodge to secure vaccine for Jersey's livestock ahead of any authorised vaccine being available in the UK."
Marc Snacken, Business Manager Livestock, Fort Dodge Europe, Africa and Middle East, said: "Jersey's farmers face a challenge not just because of their geographical closeness to France but also because of the significance of the Jersey breed in its native island home. The impact of a major outbreak of Bluetongue Serotype 1 could be devastating and, for this reason, we're delighted to be helping them with a mass vaccination campaign which will be underway shortly."